Home › Funds › Michelson Medical Research Foundation, Inc. › VEA

Michelson Medical Research Foundation, Inc. position in VEA

VANGUARD TAX-MANAGED FDS

Michelson Medical Research Foundation, Inc. reported holding 158,160 shares of VEA (VANGUARD TAX-MANAGED FDS) in its Q3 2026 13F filing — a position valued at US$11.2M, representing 9.93% of its reported portfolio and ranking #3 among its reported holdings. Michelson Medical Research Foundation, Inc. has disclosed VEA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)158.16K sh
Reported value held$11.17M
Portfolio Weight9.93%
First reportedQ3 2023
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Michelson Medical Research Foundation, Inc.'s VEA position evolved

Michelson Medical Research Foundation, Inc. first disclosed a stake in VEA in Q3 2023 at 361,160 shares (US$15.8M). The position peaked in Q3 2024 at 361,160 shares, worth US$19.1M. Across 13 filings, Michelson Medical Research Foundation, Inc. increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 11 time(s). The most recent filing (Q3 2026) shows 158,160 shares valued at US$11.2M. Notable position changes include a 56% trim in Q4 2024 (shares rose 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 361.16K $15.79M New
Q4 2023 361.16K $7.30M Hold
Q1 2024 361.16K $18.12M Hold
Q2 2024 361.16K $17.85M Hold
Q3 2024 361.16K $19.07M Hold
Q4 2024 158.16K $7.56M Reduce
Q1 2025 158.16K $8.04M Hold
Q2 2025 158.16K $9.02M Hold
Q3 2025 158.16K $9.48M Hold
Q4 2025 158.16K $9.88M Hold
Q1 2026 158.16K $10.13M Hold
Q2 2026 158.16K $11.27M Hold
Q3 2026 158.16K $11.17M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VEA and 13F data

VEA (VANGUARD TAX-MANAGED FDS) is a company whose sector is not yet classified in our data. 30 other funds we track also report a position in VEA — the largest reported positions include Bank of America Corp (US$14.25B), Betterment LLC (US$9.91B), Creative Planning (US$8.09B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VEA

All VEA fund holders →

FAQ

How long has Michelson Medical Research Foundation, Inc. held VEA?

Michelson Medical Research Foundation, Inc. has disclosed VEA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Michelson Medical Research Foundation, Inc.'s current position in VEA?

As of Q3 2026, Michelson Medical Research Foundation, Inc. holds 158.16K shares of VEA (VANGUARD TAX-MANAGED FDS), valued at $11.17M, representing 9.93% of its reported portfolio and ranking #3.

Has Michelson Medical Research Foundation, Inc. been buying or selling VEA?

In the latest 13F filing (Q3 2026), Michelson Medical Research Foundation, Inc. held unchanged its position in VEA. The position peaked in Q3 2024 at 361.16K shares.

Which other funds hold VEA?

Other major institutional holders of VEA include Bank of America Corp, Betterment LLC, Creative Planning, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.